Angong Niuhuang Pill as adjuvant therapy for treating acute cerebral infarction and intracerebral hemorrhage: A meta-analysis of randomized controlled trials
Authors:
- 1 June 2019
- journal article
- research article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 237, 307-313
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Recent Advances in the Acute Management of Intracerebral HemorrhageNeurosurgery Clinics of North America, 2018
- Anti-atherosclerosis and cardio-protective effects of the Angong Niuhuang Pill on a high fat and vitamin D3 induced rodent model of atherosclerosisJournal of Ethnopharmacology, 2017
- Treatment of acute stroke: an updateJournal of Internal Medicine, 2015
- An-Gong-Niu-Huang Wan protects against cerebral ischemia induced apoptosis in rats: Up-regulation of Bcl-2 and down-regulation of Bax and caspase-3Journal of Ethnopharmacology, 2014
- Use of Angong Niuhuang in Treating Central Nervous System Diseases and Related ResearchEvidence-Based Complementary and Alternative Medicine, 2014
- Management of Acute Ischemic StrokeHospital Practice, 2013
- Public Health Risks from Heavy Metals and Metalloids Present in Traditional Chinese MedicinesJournal of Toxicology and Environmental Health, Part A, 2007
- Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th centuryThe Lancet Neurology, 2003
- Application of Computer Tomography-Oriented Criteria for Stroke Subtype Classification in a Prospective StudyAnnals of Epidemiology, 2000